Why Attend?

Preliminary Agenda

Location & CLE

Thursday, May 7

8:15 – 9:00 AM | Registration and Continental Breakfast

Amy Comstock Rick, President & CEO, FDLI


Stephen M. Hahn, Commissioner of Food and Drugs, FDA (Invited)

10:15 – 10:45 AM | Coffee and Networking Break

10:45 – 11:45 PM | Breakout Sessions

Jeffrey E. Shuren, Director, Center for Devices and Radiological Health, FDA

11:45 AM – 12:00 PM | Transition

1:25 – 1:30 PM | Transition

1:30 – 2:30 PM | Breakout Sessions

Steven M. Solomon, Director, Center for Veterinary Medicine, FDA

2:30 – 2:40 PM | Transition

2:40 – 3:40 PM | Breakout Sessions

Mitchell R. Zeller, Director, Center for Tobacco Products, FDA

3:40 – 4:00 PM | Coffee and Networking Break

5:30 – 7:00 PM | Networking Reception

Friday, May 8

Led by a FDLI-member expert, these informal facilitated discussions provide an ideal way to engage with colleagues, gain new information, and share best practices on a hot topic in food and drug law. Attendees have the option to choose from one of the 20+ topics or enjoy open seating during breakfast.

Laura Brown, Director, Educational Programs, FDLI

Sheldon Bradshaw, Partner, King & Spalding LLP
Elizabeth Dickinson, Senior Deputy Chief Counsel, FDA Office of the Commissioner
Peter Barton Hutt, Senior Counsel, Covington & Burling LLP
Gerald Masoudi, Chief Legal Officer, Juul Labs, Inc.
Rebecca Wood, Partner, Sidley Austin LLP

10:00 – 10:20 AM | Coffee and Networking Break

10:20 – 11:20 AM | Breakout Sessions

Peter W. Marks, Director, Center for Biologics Evaluation and Research, FDA  

11:20 – 11:30 AM | Transition

11:30 – 12:30 PM | Breakout Sessions

Susan T. Mayne, Director, Center for Food Safety and Applied Nutrition, FDA

Service to FDLI Award

Presented by Amy Comstock Rick, President & CEO, FDLI and Laura Brown, Director, Educational Programs, FDLI


Dr. Harvey Wiley Lecture and FDAAA Award

A lectureship named in honor of Dr. Harvey W. Wiley, the renowned physician-chemist who, at the turn of the 20th century, championed a legislative crusade against food adulteration, earning him the title of “Father of the Pure Food and Drugs Act” when it was enacted into law in 1906.

1:40 –1:45 PM | Transition

1:45-2:45 PM | Breakout Sessions

Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA

2:45 – 3:00 PM | Coffee and Networking Break

Always informative and entertaining, this perennially popular session promises insight into the most significant litigation from 2019 and a look at cases to keep an eye on in 2020. Annual Conference attendees receive the companion publication, Top Food and Drug Law Cases 2019, and Cases to Watch, 2020

4:15 PM | Conference Adjournment